<DOC>
	<DOC>NCT00571727</DOC>
	<brief_summary>Long term study of the effects of dosing with rhIGF-1 on growth</brief_summary>
	<brief_title>Long-Term Treatment With rhIGF-1 in GHIS</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Laron Syndrome</mesh_term>
	<criteria>Height &lt;2SD for age and gender IGF1 &lt;2SD for age and gender Evidence of GH resistance closed epiphyses prior active malignancy major organ disfunction treatment with medications that would diminish growth clinically significant cardiac abnormalities</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>growth</keyword>
	<keyword>insulin like growth factor</keyword>
	<keyword>Larons syndrome</keyword>
</DOC>